Delivery Order SPE2DR25D1002-SPE2DR26FGN1H
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,156.92 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension (30-count). This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside award executed through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order valued at $11,163.12 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg Suspension in 30-count packaging. This firm fixed-price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,963.98 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension (30 count) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, utilizing a competitive award process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,633.07 to AmerisourceBergen Drug Corp for Prilosec DR 2.5 mg suspension (30 count) on September 17, 2025, with a completion date of September 18, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Prilosec DR 10 mg suspension (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $1,874.39 under a firm fixed-price arrangement, with an ultimate completion date of November 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,346.17 to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of Prilosec DR 10 mg suspension (30 count). This competitively awarded, firm fixed price delivery order is set to be completed by June 9, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs within DLA's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,636.13 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 2.5 mg Suspension (30-count units). This competitive, firm fixed-price delivery order was issued on January 15, 2026, with an ultimate completion date of January 16, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating full and open competition. AmerisourceBergen...
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $2,685.17, is for the provision of Prilosec DR 10 mg suspension medication to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Prilosec DR 10 mg suspension (30-count), a proton pump inhibitor commonly used to treat gastroesophageal reflux disease and related gastrointestinal conditions. The contract is valued at $1,626.78 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 31, 2025. This award carries no set-aside designation and was competitively...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension. The delivery order has a total ceiling value of $14,212.64 and an ultimate completion date of September 26, 2024. The contract is a firm-fixed-price arrangement, and no set-aside designation was used. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC)...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGN1HDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,602.00 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg Suspension (30-count). This competitive award, issued on January 21, 2026, with an ultimate completion date of January 22, 2026, represents a firm fixed-price transaction with no set-aside designation. The contractor will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This award falls under AmerisourceBergen's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999.99 million through December 31, 2031, serving as the comprehensive vehicle for pharmaceutical and medical supply deliveries to support military healthcare systems globally. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical procurement ecosystem, regularly fulfilling delivery orders for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA Troop Support Medical division leverages its relationship with major pharmaceutical distributors like AmerisourceBergen to ensure consistent availability of essential medications to military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs worldwide. This specific order for Prilosec, a proton pump inhibitor commonly used for gastroesophageal reflux disease treatment, exemplifies the routine pharmaceutical procurement activities conducted through the broader indefinite delivery contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/20/26 |